Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Olivares-Berjaga

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Molecular Sciences|September 13, 2025
The Potential of Hair Matrix for Biomarker Analysis in SchizophreniaEnric Rubio-Contreras, Nora Guasch-Capella, Albert Martínez-Pinteño, et al.
Translational Psychiatry|January 14, 2025
Effectiveness of positive allosteric modulators of metabotropic glutamate receptor 2/3 (mGluR2/3) in animal models of schizophreniaDavid Olivares-Berjaga, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Schizophrenia Research|June 16, 2026
Increased brain VDAC1 protein levels correlate with behavioural performance in a ketamine murine model of schizophrenia and are attenuated by the mGluR2 modulator JNJ-46356479David Olivares-Berjaga, Natàlia Rodríguez, Albert Martínez-Pinteño, et al.
International Journal of Molecular Sciences|May 14, 2025
Mitochondrial Oxidative Phosphorylation System Dysfunction in SchizophreniaConstanza Morén, David Olivares-Berjaga, Albert Martínez-Pinteño, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 12, 2025
Effects of JNJ-46356479 and clozapine on VGLUT1 and GAD65/67 brain levels and expression of genes related to glutamate and GABA in mice postnatally exposed to ketamineAlbert Martínez-Pinteño, David Olivares-Berjaga, Natalia Rodríguez, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2024
Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophreniaDavid Olivares-Berjaga, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Psychiatry Research|January 10, 2024
Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic riskLlucia Prohens, Natalia Rodríguez, Àlex-Gonzàlez Segura, et al.
Translational Psychiatry|November 1, 2025
Association of astrocyte-specific gene expression in the dorsolateral prefrontal cortex with clozapine treatment in schizophreniaLlucia Prohens, Natalia Rodríguez, Àlex-Gonzàlez Segura, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|September 13, 2025
The Potential of Hair Matrix for Biomarker Analysis in SchizophreniaEnric Rubio-Contreras, Nora Guasch-Capella, Albert Martínez-Pinteño, et al.
Translational Psychiatry|January 14, 2025
Effectiveness of positive allosteric modulators of metabotropic glutamate receptor 2/3 (mGluR2/3) in animal models of schizophreniaDavid Olivares-Berjaga, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Schizophrenia Research|June 16, 2026
Increased brain VDAC1 protein levels correlate with behavioural performance in a ketamine murine model of schizophrenia and are attenuated by the mGluR2 modulator JNJ-46356479David Olivares-Berjaga, Natàlia Rodríguez, Albert Martínez-Pinteño, et al.
International Journal of Molecular Sciences|May 14, 2025
Mitochondrial Oxidative Phosphorylation System Dysfunction in SchizophreniaConstanza Morén, David Olivares-Berjaga, Albert Martínez-Pinteño, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 12, 2025
Effects of JNJ-46356479 and clozapine on VGLUT1 and GAD65/67 brain levels and expression of genes related to glutamate and GABA in mice postnatally exposed to ketamineAlbert Martínez-Pinteño, David Olivares-Berjaga, Natalia Rodríguez, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 31, 2024
Effects of the PAM of mGluR2, JNJ-46356479, on brain apoptotic protein levels in a mouse model of schizophreniaDavid Olivares-Berjaga, Albert Martínez-Pinteño, Natalia Rodríguez, et al.
Psychiatry Research|January 10, 2024
Gene expression imputation provides clinical and biological insights into treatment-resistant schizophrenia polygenic riskLlucia Prohens, Natalia Rodríguez, Àlex-Gonzàlez Segura, et al.
Translational Psychiatry|November 1, 2025
Association of astrocyte-specific gene expression in the dorsolateral prefrontal cortex with clozapine treatment in schizophreniaLlucia Prohens, Natalia Rodríguez, Àlex-Gonzàlez Segura, et al.
Pageof 1